Literature DB >> 27797895

Viral-Associated GN: Hepatitis C and HIV.

Warren L Kupin1.   

Abstract

Viruses are capable of inducing a wide spectrum of glomerular disorders that can be categorized on the basis of the duration of active viremia: acute, subacute, or chronic. The variable responses of the adaptive immune system to each time period of viral infection results mechanistically in different histologic forms of glomerular injury. The unique presence of a chronic viremic carrier state with either hepatitis C (HCV) or HIV has led to the opportunity to study in detail various pathogenic mechanisms of viral-induced glomerular injury, including direct viral infection of renal tissue and the development of circulating immune complexes composed of viral antigens that deposit along the glomerular basement membrane. Epidemiologic data show that approximately 25%-30% of all HIV patients are coinfected with HCV and 5%-10% of all HCV patients are coinfected with HIV. This situation can often lead to a challenging differential diagnosis when glomerular disease occurs in this dual-infected population and requires the clinician to be familiar with the clinical presentation, laboratory workup, and pathophysiology behind the development of renal disease for both HCV and HIV. Both of these viruses can be categorized under the new classification of infection-associated GN as opposed to being listed as causes of postinfectious GN as has previously been applied to them. Neither of these viruses lead to renal injury after a latent period of controlled and inactive viremia. The geneses of HCV- and HIV-associated glomerular diseases share a total dependence on the presence of active viral replication to sustain renal injury so the renal disease cannot be listed under "postinfectious" GN. With the new availability of direct-acting antivirals for HCV and more effective combined antiretroviral therapy for HIV, successful remission and even regression of glomerular lesions can be achieved if initiated at an early stage.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  APOL1; Antigen-Antibody Complex; Antigens; Antiviral Agents; Carrier State; Coinfection; Diagnosis; Differential; Glomerular Basement Membrane; Glomerulonephritis; HIV Infections; Hepacivirus; Hepatitis C; Humans; Immune System; Viral; Viremia; focal segmental glomerulosclerosis; hantavirus kidney; polyarteritis nodosa HCV

Mesh:

Substances:

Year:  2016        PMID: 27797895      PMCID: PMC5544506          DOI: 10.2215/CJN.04320416

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  36 in total

1.  Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.

Authors:  Meghan E Sise; Allyson K Bloom; Jessica Wisocky; Ming V Lin; Jenna L Gustafson; Andrew L Lundquist; David Steele; Michael Thiim; Winfred W Williams; Nikroo Hashemi; Arthur Y Kim; Ravi Thadhani; Raymond T Chung
Journal:  Hepatology       Date:  2015-12-11       Impact factor: 17.425

Review 2.  Defeating AIDS--advancing global health.

Authors:  Peter Piot; Salim S Abdool Karim; Robert Hecht; Helena Legido-Quigley; Kent Buse; John Stover; Stephen Resch; Theresa Ryckman; Sigrun Møgedal; Mark Dybul; Eric Goosby; Charlotte Watts; Nduku Kilonzo; Joanne McManus; Michel Sidibé
Journal:  Lancet       Date:  2015-06-24       Impact factor: 79.321

3.  Increase in nonhepatic diagnoses among persons with hepatitis C hospitalized for any cause, United States, 2004-2011.

Authors:  X Tong; P R Spradling
Journal:  J Viral Hepat       Date:  2015-04-20       Impact factor: 3.728

Review 4.  HIV-associated immune complex kidney disease.

Authors:  Ehsan Nobakht; Scott D Cohen; Avi Z Rosenberg; Paul L Kimmel
Journal:  Nat Rev Nephrol       Date:  2016-01-19       Impact factor: 28.314

5.  Hepatitis C virus-associated polyarteritis nodosa.

Authors:  D Saadoun; B Terrier; O Semoun; D Sene; T Maisonobe; L Musset; Z Amoura; M Resche Rigon; P Cacoub
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10-27       Impact factor: 4.794

6.  The clinical and histological response of HIV-associated kidney disease to antiretroviral therapy in South Africans.

Authors:  June Fabian; Saraladevi Naicker; Stewart Goetsch; Willem Daniel Francois Venter
Journal:  Nephrol Dial Transplant       Date:  2013-02-26       Impact factor: 5.992

Review 7.  The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review.

Authors:  Franco Dammacco; Vito Racanelli; Sabino Russi; Domenico Sansonno
Journal:  Clin Exp Med       Date:  2016-03-02       Impact factor: 3.984

Review 8.  IgA nephropathy and infections.

Authors:  Cristiana Rollino; Gisella Vischini; Rosanna Coppo
Journal:  J Nephrol       Date:  2016-01-22       Impact factor: 3.902

Review 9.  Hepatitis C drugs: the end of the pegylated interferon era and the emergence of all-oral interferon-free antiviral regimens: a concise review.

Authors:  Alan Hoi Lun Yau; Eric M Yoshida
Journal:  Can J Gastroenterol Hepatol       Date:  2014-09

10.  Nephrotoxicity of HAART.

Authors:  Robert Kalyesubula; Mark A Perazella
Journal:  AIDS Res Treat       Date:  2011-08-15
View more
  14 in total

1.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

2.  Reversal of Donor Hepatitis C Virus-Related Mesangial Proliferative GN in a Kidney Transplant Recipient.

Authors:  Pascale Khairallah; Satoru Kudose; Heather K Morris; Lloyd E Ratner; Sumit Mohan; Jai Radhakrishnan; Jae-Hyung Chang
Journal:  J Am Soc Nephrol       Date:  2020-09-16       Impact factor: 10.121

3.  Advances in the Management of Renal Dysfunction in Patients With Cirrhosis.

Authors:  Nathalie A Pena Polanco; Paul Martin; Andres F Carrion
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-05

4.  Metabolic Syndrome in HIV/HCV Co-infected Patients.

Authors:  Lauren F Collins; Ruth O Adekunle; Emily J Cartwright
Journal:  Curr Treat Options Infect Dis       Date:  2019-12-02

Review 5.  Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease.

Authors:  Marco Ladino; Fernando Pedraza; David Roth
Journal:  World J Hepatol       Date:  2017-07-08

6.  Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature.

Authors:  Michele Mirabella; Lucia Taramasso; Laura Ambra Nicolini; Rodolfo Russo; Claudio Viscoli; Antonio Di Biagio
Journal:  Clin Nephrol Case Stud       Date:  2018-10-26

7.  Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report.

Authors:  Yi Huang; Xiao-Juan Li; Yue-Qiang Li; Wei Dai; Tiffany Shao; Wei-Yong Liu; Min Han; Gang Xu; Liu Liu
Journal:  BMC Nephrol       Date:  2020-11-24       Impact factor: 2.388

8.  Membranous nephropathy in patients with HIV: a report of 11 cases.

Authors:  Vivek Charu; Nicole Andeen; Vighnesh Walavalkar; Jessica Lapasia; Jin-Yon Kim; Andrew Lin; Richard Sibley; John Higgins; Megan Troxell; Neeraja Kambham
Journal:  BMC Nephrol       Date:  2020-09-18       Impact factor: 2.388

Review 9.  Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV.

Authors:  Jack Edward Heron; Corinne Isnard Bagnis; David M Gracey
Journal:  AIDS Res Ther       Date:  2020-03-16       Impact factor: 2.250

Review 10.  Targeting acute kidney injury in COVID-19.

Authors:  John A Kellum; J W Olivier van Till; George Mulligan
Journal:  Nephrol Dial Transplant       Date:  2020-10-01       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.